Back to CITIGROUP INC CITIGROUP INC

EGRXEGRX
Showing 2 of 5 quarters

Position history for CITIGROUP INCCITIGROUP INC's holdings in EAGLE PHARMACEUTICALS INC

No. Citigroup exited its EGRX (Eagle Pharmaceuticals) position in Q4 2024. Its Q3 2024 13F listed 1,000,389 shares worth $3.7M. Citigroup already held EGRX in its Q4 2023 13F, the earliest on record, and held it in 4 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$3.7M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.50
0
2024-Q3
Decreased
1M
-0.1%
$3.7M0.0%$3.95
0

Other major holders of EGRX: Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used